ToLong-term owners & members
FromThe research desk, zh.app
Re941 companies under coverage — what deserves attention now

Investment research through a long-term owner's lens

The Zen Horizon Framework, dissecting the business quality, moats, and intrinsic value of AI, technology, and global equities — with a clear read on the margin of safety.

951 reports 14 topics 941 tickers
More research →
40/100 Hold Sumitomo Electric Industries: The Transition Is Real, But So Is the Price Sumitomo Electric is a diversified Japanese cable-and-components maker whose profit mix is shifting away from its low-margin automotive wire-harness base toward higher-margin AI-driven optical interconnects and high-voltage power cables. FY2025 sales reached ¥5.11 trillion with operating profit up 30.4% to ¥418.2 billion, but a meaningful share of the profit surge came from a one-off ¥79.2 billion asset-sale gain, and management's own FY2027 guidance implies only modest further growth. Rating Hold: at ¥2,458.5 the stock already prices much of the transition, leaving no margin of safety at the current level. Sumitomo Electric Industries, Ltd.5802 · TSEElectrical EquipmentJul 15, 2026 46/100 Hold Jazz Pharmaceuticals: A Fair Price for an Unfinished Second Act Jazz Pharmaceuticals is an Irish-domiciled specialty biopharma whose durable Xywav/Xyrem sleep franchise has funded a pivot into rare epilepsy (Epidiolex) and oncology (zanidatamab, Modeyso, Zepzelca). 2025 revenue reached $4.27 billion with $1.36 billion of operating cash flow, and Q1 2026 revenue grew 19% to $1.069 billion as the market now turns on zanidatamab's August 25, 2026 FDA decision in first-line gastric cancer and on how long Xywav can outrun Lumryz and generic competition. Rating Hold: at $238.05 the stock already prices durable Xywav defense and a timely zanidatamab step-up, leaving no meaningful margin of safety. Jazz Pharmaceuticals plcJAZZ · USPharmaceuticalsJul 15, 2026 33/100 Avoid Uranium Energy Corp: Scarce U.S. Uranium Assets, Priced Ahead of the Proof Uranium Energy Corp is a U.S. in-situ-recovery uranium miner running the country's only two active ISR production hubs, in Wyoming and South Texas, while building toward a domestic conversion business through its UR&C subsidiary. The balance sheet is genuinely strong, with $489.9 million in cash plus restricted cash and no debt as of April 2026, but five-year operating cash flow totaled roughly negative $192.8 million, 2025 revenue of $66.8 million still came mainly from selling purchased inventory rather than mined output, and shares outstanding rose from 378.5 million to 493.3 million since 2023. Rating Avoid: the licensed U.S. permits and policy tailwinds are real, but at $10.07 the stock already sits above even the report's optimistic per-share fair value of $9.02, leaving no margin of safety. Uranium Energy Corp.UEC · USNuclear Fuel CycleJul 14, 2026 45/100 Watch Vicor: A Real Power-Delivery Specialist, Already Priced For AI's Promise Vicor is a specialist power-conversion supplier whose Factorized Power Architecture and modular DC-DC building blocks target the 'last-inch' power-delivery bottleneck between AI processors and the board, monetizing both product sales and a fast-growing patent-royalty stream. Full-year 2025 revenue rose 13.5% to $407.7 million with gross margin reaching 57.3% as royalty revenue grew from $15.9 million in 2023 to $57.4 million in 2025, and first-quarter 2026 backlog jumped 75% year over year to $301 million, yet the company still has not disclosed the hyperscaler customers the market assumes it serves. Rating Watch: the technical edge and momentum are real, but at a trailing P/E above 84x and zero margin of safety against the conservative scenario, the stock already prices years of unproven customer breadth. Vicor CorporationVICR · USAI 电源与功率器件Jul 14, 2026
All insights →
AI Circular Financing: Stroke of Genius or the Ponzi of the Century? We Counted Every Dollar in the Loop

NVIDIA invests in OpenAI, OpenAI signs hundreds of billions of dollars in compute purchases from Microsoft, Oracle, and CoreWeave, and those buyers turn around and buy NVIDIA chips — bulls call this loop a virtuous circle, bears compare it to Cisco in 2000. After checking every deal against primary documents, our verdict: the cash genuinely moves and SEC disclosure reaches the contract level, so the Ponzi label fails; but NVIDIA's top three customers already account for 54% of a single quarter's revenue, and the credit risk of vendor financing is concentrating in the chain's anchor. We put the subjective odds of a contract-level crack among the loop's core parties before the end of 2027 at roughly 65% — and since June the market has already begun pricing the two ends of the loop apart.

Industry Landscape Jul 7, 2026
Growth Score Index, 2026 Q2: Only One Company in 897 Clears the Bar

First edition of our quarterly Growth Score Index, built from 897 fully scored companies in the Zen Horizon research library. The median score is 43/100 and exactly one company clears 65, because the test is a credible ten-year 5x path, and durable quality turns out to be far more common than durable hypergrowth. Twelve names combine a top-decile score with a price below our fair-value band.

Data Report Jul 3, 2026
Has the Memory Supercycle Topped? Our 71 Chip Scorecards Had the Answer Before the Crash

In early June, Micron fell hard from its all-time high, dropping as much as 13.3% intraday in a single session and pushing the question "has the AI memory supercycle topped?" to center stage. This piece uses our 71 semiconductor Baillie Ten-Question scorecards to make a contrarian call: the demand supercycle is real, but after Micron and Hynix rose roughly tenfold and crossed a trillion in market cap, the stocks have been priced to perfection. None of the 71 scores above 3 on either the expectations-in-the-share-price question or the what-the-market-is-missing question. The verdict: this is valuation reverting to cyclical fragility, not demand collapsing, and the most dangerous trade is buying the dip. We put the subjective odds of Micron drawing down at least 25% from its June 3 high within 12 months at roughly 60%.

Industry Landscape Jun 15, 2026
What Is a Spot in the S&P 500 Actually Worth? The Passive Buying Is Real, but the Inclusion Premium Is Gone

When a big company joins the S&P 500, index funds are genuinely forced by the rules to buy it. The "inclusion premium" that used to come with that, though, has all but vanished over the past two decades. Drawing on the membership rules of the three major index families, the mechanical buying from $20 trillion in passive money, and first-hand academic evidence on the "disappearing index effect," this piece asks what a spot in an index is really worth. The verdict: passive demand equals roughly 7–8% of a new member's float and is genuinely measurable, but the excess return from announcement to effective date has fallen from 7.4% in the 1990s to 0.3% over the last decade. SpaceX cannot get into the S&P 500 and is about 15 trading days from the Nasdaq-100; its rock-bottom 4.25% float is the real variable.

Policy Impact Jun 13, 2026